1.Review of research progress on the application of transcranial direct current stimulation on healthy individual cognitive function enhancement
Military Medical Sciences 2024;48(4):303-310
Cognitive function enhancement refers to the process of enhancing one or more core component of human brain cognition.Transcranial direct current stimulation(tDCS),as a non-invasive neuromodulation technique,can regulate brain cortical excitability,synaptic plasticity and brain networks functional connection.tDCS can be used to modulate cognitive function components,such as perception,working memory,attention,motor learning and decision-making.This article reviews the neural and physiological mechanism of tDCS over cerebral cortex modulating neural activity and the research progress in human cognitive performance ofsingle tDCS on perception,working memory,attention,motor learning,decision-making and language of healthy individuals in order to provide reference for researchers.
2.Clinical characteristics and predictors of mortality in patients with candidemia in intensive care unit
Huiying ZHAO ; Qi WANG ; Peihua WU ; Guangjie WANG ; Huixia WANG ; Fengxue ZHU ; Youzhong AN
Chinese Critical Care Medicine 2018;30(10):929-932
Objective To investigate the clinical characteristics and predictors of mortality in patients with candidemia in intensive care unit (ICU). Methods The patients with candidemia admitted to ICU of Peking University People's Hospital from January 2010 to December 2017 were enrolled. The general clinical data, indicators related to Candidia infection and prognosis were collected, and the clinical characteristics, infection characteristics and prognosis of patients with candidiasis were analyzed. Patients were divided into death group and survival group according to hospital survival status. The differences of each index were compared between two groups. The independent risk factors of mortality in patients with candidemia were analyzed by multivariate Logistic regression analysis. Results A total of 95 patients (55 males) with candidemia were included, with an average age of (69.3±16.5) years, acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ) was 24.7±3.6, sequential organ failure assessment (SOFA) was 6.6±2.7. Candida albicans accounted for the largest proportion of Candida infections (n = 56, 58.9%). Thirty-two (33.7%) patients received inadequate antifungal therapy and 38 (40.0%) patients received inadequate source control. Fifty-five (57.9%) patients were died in hospital. Compared with the survival group, patients in the death group was older (years: 72.5±14.6 vs. 64.9±18.0, P < 0.05), had higher APACHEⅡ and SOFA scores (26.6±2.2 vs. 22.1±3.6, 7.9±2.0 vs. 4.7±2.4, both P ﹤ 0.01), higher rate of glucocorticoid treatment (18.2% vs. 10.0%, P < 0.05), and higher proportion of Candida albicans and Candida glabrata (69.1% vs. 45.0%, 10.9% vs. 7.5%, both P < 0.05), the rate of multi-site Candida infection also significantly increased (47.3% vs. 17.5%, P < 0.05). Intra-abdominal infection was the primary infection site and more common in death group (49.1% vs. 35.0%, P < 0.05). The rates of sepsis (87.3% vs. 62.5%), inadequate antifungal therapy (49.1% vs. 10.0%), inadequate source control (60.0% vs. 12.5%) in death group were all higher than those in survival group (all P < 0.01). It was shown by multivariate Logistic regression analysis that APACHE Ⅱ[odds ratio (OR) = 1.605, P = 0.002, β = 0.473], SOFA (OR = 1.501, P = 0.029, β = 0.406), inadequate antifungal therapy (OR = 12.084, P = 0.006, β = 2.492) and inadequate source control (OR = 7.332, P = 0.024, β = 1.992) were independent risk factors for mortality in ICU patients with candidemia. Conclusions Candidemia patients were severe and had poor prognosis. APACHE Ⅱ, SOFA, inadequate antifungal therapy and inadequate source control were independent risk factors of mortality.
3.Expression, purification and characterization of N-glycanase from Schizosaccharomyces pombe in Escherichia coli.
Fengxue XIN ; Peng WANG ; Shenghua ZHONG ; Qingsheng QI
Chinese Journal of Biotechnology 2008;24(4):592-597
One pair of primers were designed and synthesized on the base of the cDNA sequence encoding Schizosaccharomyces pombe N-glycanase reported on the GenBank. The cDNA sequence encoding Peptide N-glycanase was cloned from the Schizosaccharomyces pombe by RT-PCR. And then the RT-PCR product was cloned into the expression vector pET-15b. The expression vector pET-15b(+)/Png1p was transformed into E. coli BL21(DE3). The results showed that the relative molecular weight of the enzyme was determined to be approximately 39 kD using SDS-PAGE. The expression products after induction and purification can catalyze the cleavage of N-linked oligosaccharides from glycoprotein coped with heat, but have no action on the native glycoprotein with the help of DTT. The percentage of deglycosylated RNase B treated with equate Png1p in different reaction temperature, pH, concentration of DTT and denatured temperature showed that the optimum temperature, the optimum pH is 30 degrees C; the optimum concentration of DTT is 10 mmol/L and the optimum denatured temperature is 100 degrees C.
Cloning, Molecular
;
Escherichia coli
;
genetics
;
metabolism
;
Glycosylation
;
Hydrogen-Ion Concentration
;
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase
;
biosynthesis
;
genetics
;
metabolism
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
isolation & purification
;
Schizosaccharomyces
;
enzymology
;
genetics
;
Temperature

Result Analysis
Print
Save
E-mail